This 2020 electron microscope made available by the U.S. Centers for Disease Control and Prevention image shows the spherical coronavirus particles from the first U.S. case of COVID-19. A recent study sparked some worry last week when it revealed a mutation “of urgent concern” in the virus responsible for COVID-19. But experts say more research is needed to determine what that really means.The preliminary, non peer-reviewed study from the Los Alamos National Laboratory in New Mexico indicated that a COVID-19 strand containing a specific mutation — on the spike protein D614G — is emerging as the dominant form of the virus. THE CANADIAN PRESS/AP-C.S. Goldsmith, A. Tamin/ CDC via AP

This 2020 electron microscope made available by the U.S. Centers for Disease Control and Prevention image shows the spherical coronavirus particles from the first U.S. case of COVID-19. A recent study sparked some worry last week when it revealed a mutation “of urgent concern” in the virus responsible for COVID-19. But experts say more research is needed to determine what that really means.The preliminary, non peer-reviewed study from the Los Alamos National Laboratory in New Mexico indicated that a COVID-19 strand containing a specific mutation — on the spike protein D614G — is emerging as the dominant form of the virus. THE CANADIAN PRESS/AP-C.S. Goldsmith, A. Tamin/ CDC via AP

Halifax lab team to conduct first Canadian trials for possible COVID-19 vaccine

Lab was involved in trials that led to creation of Ebola vaccine

The first Canadian clinical trials for a possible COVID-19 vaccine will be conducted by a Halifax research team that also was involved in trials that eventually led to a vaccine for the Ebola virus.

Health Canada has approved trials that will be conducted at the Canadian Centre for Vaccinology at Dalhousie University.

The centre’s director, Dr. Scott Halperin, says the lab was one of several in Canada and the U.S. whose work starting in 2014 eventually saw an “emergency release” of an Ebola vaccine that was used in West Africa before a third phase of clinical trials had been completed.

Halperin said each lab did slightly different studies in order to get the right type of information before quickly moving to the second phase and then the third.

“The Phase 1 studies were done and within six months the data were available and the phase three studies were started in West Africa which then helped to actually stop the epidemic,” he said in an interview.

Halperin said it’s possible the same emergency release could happen in Canada with a potential COVID-19 vaccine if it shows potential and is deemed safe, expediting a process that usually takes a number of years to complete — anywhere from five to seven years under normal circumstances.

“That would be something that Health Canada and the Canadian government would have to decide whether they wanted to do that. But it is certainly one of the options in the tool kit of things they can do to expedite the process if this or any other vaccine is looking promising.”

READ MORE: First clinical trial for potential COVID-19 vaccine in Canada approved: Trudeau

Halperin pointed out that despite its early use during testing, the Ebola vaccine wasn’t actually licensed as a regular marketed vaccine until late last year.

However, he cautions there’s much work to be done before a COVID-19 vaccine could be approved for use.

The Halifax researchers will be following up work by Chinese manufacturer CanSino Biologics, which is already conducting human clinical trials for the vaccine.

Halperin said the first phase trial should be underway within the next three weeks once final approval is given by the centre’s research ethics board.

Phase 1 will involve fewer than 100 healthy volunteers between the ages of 18 and 55 who will be followed over the next six months.

“We want to make sure that the vaccine is safe first in younger individuals before we go into people who may be at higher risk,” Halperin said.

The participants are given a dose of the vaccine and are clinically monitored through a series of blood tests. They are also asked to record their symptoms in a diary so the researchers can have even more information.

“We collect any type of symptoms they might have whether they think it’s related to the vaccine or not,” said Halperin.

Each participant will make between nine and 13 visits to the centre during the first phase of the study.

If the initial test group shows a safe immune response to the vaccine, Halperin said researchers will quickly transition into an expanded second phase study before the first phase is even completed.

That would involve hundreds of people of all ages, including those aged 65 to 85, and would be administered by several other research centres across the country that are part of the Canadian Immunization Research Network.

Halperin said the network was set up by the federal government in 2009 as part of the response to the H1N1 pandemic. He said the intent was to create the necessary infrastructure to respond rapidly to an emergency and to do early phase clinical trials so vaccines would be available in Canada.

“This is a good test of that (network),” Halperin said of clinical trials that will be the first of “many more to come.”

Keith Doucette, The Canadian Press


Like us on Facebook and follow us on Twitter.

Want to support local journalism during the pandemic? Make a donation here.

CanadaCoronavirusvaccines

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

In past years, members of the Summerland Fire Department were present at the Summerland Festival of Lights to collect donations for the annual Toys and Toonies for Tots and Teens gift drive. This year, because of the COVID-19 pandemic, the festival will not be happening, but the annual toy drive will proceed. Donations of cash or new unwrapped toys will be accepted at the Summerland Fire Hall and the Summerland CIBC branch until Dec. 10. (Summerland Review file photo)
Donations sought for Summerland’s annual toy drive

Cash and new unwrapped toys accepted until Dec. 10 for Toys and Toonies for Tots and Teens

RCMP Cpl. Cory Lepine pictured at BC Livestock Producers Co. in Kamloops, Nov. 16. (Phil McLachlan - Black Press Media)
Meet B.C.’s only cowboy cop; a voice for the livestock industry

Cpl. Cory Lepine serves as a bridge between the law and those who make a living off the land

Grizzly.
Morning Start: Humans might be able to hibernate like bears

Your morning start for Tuesday, Nov. 24, 2020

A man wearing a face mask to help curb the spread of COVID-19 walks in downtown Vancouver, B.C., Sunday, Nov. 22, 2020. The use of masks is mandatory in indoor public and retail spaces in the province. THE CANADIAN PRESS/Darryl Dyck
104 new COVID-19 cases in Interior Health

IH is reporting the new numbers since Friday, Nov. 20

Penticton RCMP are looking to speak to this woman who allegedly spat on an employee at Skaha Liquor Store as well as dropping his phone on the ground. (Facebook)
WATCH: Unmasked Penticton woman allegedly spits on employee, drops his phone

Penticton RCMP are looking for the woman who was refused service for not wearing a mask

The Animal Food Bank is asking for donations as the pandemic continues and the holidays approach. (Twila Amato - Black Press Media)
Okanagan Animal Food Bank in need of donations as pandemic continues

The Animal Food Bank provides food for any domestic pet in need

Join Black Press Media and Do Some Good
Join Black Press Media and Do Some Good

Pay it Forward program supports local businesses in their community giving

(Black Press Media files)
B.C. to test emergency alert system on cell phones, TVs, radios on Wednesday

The alert is part of a twice yearly test of the national Alert Ready system

Prime Minister Justin Trudeau speak to the media about the COVID-19 virus outside Rideau Cottage in Ottawa, Friday, Nov. 20, 2020. THE CANADIAN PRESS/Adrian Wyld
Canada’s inability to manufacture vaccines in-house will delay distribution: Trudeau

First doses of COVID-19 vaccine expected in first few months of 2021, prime minister says

Kelowna International Airport. ���Image: Capital News file
Two more Kelowna flights exposed to COVID-19

At least seven Kelowna flights have been exposed to COVID-19 since Oct. 21

Phillip Tallio was just 17 when he was convicted of murder in 1983 (file photo)
Miscarriage of justice before B.C. teen’s 1983 guilty plea in girl’s murder: lawyer

Tallio was 17 when he pleaded guilty to second-degree murder in the death of his 22-month-old cousin

This undated photo issued by the University of Oxford shows of vial of coronavirus vaccine developed by AstraZeneca and Oxford University, in Oxford, England. Pharmaceutical company AstraZeneca said Monday Nov. 23, 2020, that late-stage trials showed its coronavirus vaccine was up to 90% effective, giving public health officials hope they may soon have access to a vaccine that is cheaper and easier to distribute than some of its rivals. (University of Oxford/John Cairns via AP)
VIDEO: How do the leading COVID vaccines differ? And what does that mean for Canada?

All three of the drug companies are incorporating novel techniques in developing their vaccines

An aerial shot of Cedar Valley Lodge this past August, LNG Canada’s newest accommodation for workers at the project site in Kitimat. This is where several employees are isolating after a COVID-19 outbreak was declared last Thursday (Nov. 19). (Photo courtesy of LNG Canada)
Forty-one positive COVID-19 cases associated with the LNG Canada site outbreak in Kitimat

Thirty-four of the 41 cases remain active, according to Northern Health

A concept rendering of the proposed Costco at the corner of Baron, Leckie and Springfield roads. (WSP Global)
Contentious Kelowna Costco relocation moved to public hearing

Costco looking to move less than a kilometre away to build a larger store with more parking, gas bar

Most Read